$85.39
-0.320 (-0.373%)
At Close: Jul 31, 2026
Better Buy: Intuitive Surgical vs. Medtronic
02:30pm, Thursday, 17'th Mar 2022 The Motley Fool
Both are two exceptional growth stocks -- but which is the better choice for investors now?
Better Buy: Intuitive Surgical vs. Medtronic
10:30am, Thursday, 17'th Mar 2022
Both are two exceptional growth stocks -- but which is the better choice for investors now?
Medtronic''s US Trial Of GI Genius Endoscopy Module Reduces Missed Colorectal Polyps By 50%
06:28pm, Wednesday, 16'th Mar 2022 Benzinga
Medtronic plc (NYSE: MDT ) announced final findings from a study that confirmed the effectiveness of the GI Genius intelligent endoscopy module. GI Genius uses AI to aid in detecting colorectal polyps during colonoscopy, potentially helping to prevent colorectal cancer (CRC). The study published in Gastroenterology found … Full story available on Benzinga.com
Medtronic highlights potential of GI Genius in prevention of colorectal cancer (NYSE:MDT)
02:11pm, Wednesday, 16'th Mar 2022 Seeking Alpha
Medtronic (MDT) announced final data from an international multi-center study on Wednesday to claim that its GI Genius endoscopy module used in colonoscopy can lead to a 50% reduction…
Here's Why You Should Hold on to Medtronic (MDT) Stock For Now
12:42pm, Tuesday, 15'th Mar 2022 Zacks Investment Research
Investors are optimistic about Medtronic's (MDT) better-than-expected earnings and strong market share gains.
Here's Why You Should Hold on to Medtronic (MDT) Stock For Now
09:47am, Tuesday, 15'th Mar 2022
Investors are optimistic about Medtronic's (MDT) better-than-expected earnings and strong market share gains.
Upcoming Ex-Dividend Dates: March 16-31, 2022
09:00am, Tuesday, 15'th Mar 2022
We provide a summary of upcoming ex-dividend dates in a quick reference table.
A Look Inside SPY And VOO: What's Changed Since December 31, 2021
05:49am, Monday, 14'th Mar 2022 Seeking Alpha
VOO and other S&P 500 index funds report data that can lag for as much as two months behind. We compare metrics of VOO as of January 31, 2022 and those of SPY now to see how they differ.
Global Central Venous Catheters (CVCs) Market to Reach $1.5 Billion by 2026
04:26pm, Friday, 11'th Mar 2022 Benzinga
SAN FRANCISCO , March 11, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Central Venous Catheters (CVCs) - Global Market Trajectory & Analytics" . The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace. FACTS AT A GLANCE What''s New for 2022? Global competitiveness and key competitor percentage market shares Market presence across multiple geographies - Strong/Active/Niche/Trivial Online interactive peer-to-peer collaborative bespoke updates Access to our digital archives and MarketGlass Research Platform Complimentary updates for one year Edition: 7; Released: February 2022 Executive Pool: 4019 Companies: 61 - Players covered include Amecath; AngioDynamics Inc.; B. Braun Melsungen AG; Bactiguard AB; Becton, Dickinson and Company; COOK MEDICAL LLC; Edwards Lifesciences Corporation; Guangdong Baihe Medical Technology Co., Ltd; ICU Medical, Inc.; Insung Medical Co.
The "Carotid and Renal Artery Stents (Cardiovascular) - Global Market Analysis and Forecast Model" report has been added to ResearchAndMarkets.com''s offering. Carotid and Renal Artery Stents (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area. The model discusses in detail the impact of COVID-19 on Carotid and Renal Artery Stents market for the year 2020 and beyond. Three types of therapies are recommended for carotid stenosis. These therapies include medication, endovascular intervention, and endarterectomy. Endarterectomy is recommended over stenting to patients who are suffering from stenosis (>70%) and have had symptoms for the last six months to a year. It is not recommended to individuals with 50% or less stenosis in the carotid artery. Endovascular therapy is … Full story available on Benzinga.com
Medtronic (MDT) Inks Deal to Offer Touch Surgery Enterprise
02:10pm, Thursday, 10'th Mar 2022 Zacks Investment Research
Medtronic's (MDT) Touch Surgery Enterprise gives surgical teams a powerful new tool to enhance patient care by simplifying the process to capture and analyze surgical videos.
Rockley Photonics and Medtronic Collaborate to Deliver the Next Generation of Wearable Healthcare Monitoring Devices
02:05pm, Thursday, 10'th Mar 2022 Business Wire
OXFORD, England & PASADENA, Calif.--(BUSINESS WIRE)--Rockley Photonics Holdings Limited (NYSE: RKLY) (“the Company” or “Rockley”), a global leader in photonics-based health monitoring and communications solutions, today announced that it has agreed to enter a development partnership with Medtronic, a global leader in healthcare technology. The two companies plan to collaborate to bring Rockley’s recently announced Bioptx™ biomarker sensing platform into Medtronic’s solutions for use across vari
Biden meets with CEOs of Micron, HP, Medtronic in push for spending on chip manufacturing
01:32pm, Thursday, 10'th Mar 2022 MarketWatch
President Joe Biden meets Wednesday afternoon with executives from big U.S. tech companies, as he continues his push to get billions of dollars for semiconductor manufacturing.
Medtronic (MDT) Inks Deal to Offer Touch Surgery Enterprise
10:32am, Thursday, 10'th Mar 2022
Medtronic's (MDT) Touch Surgery Enterprise gives surgical teams a powerful new tool to enhance patient care by simplifying the process to capture and analyze surgical videos.
released a new market study on 2022-2028 Interventional Oncology Ablation Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The global research report delivers an in-depth
Sign In
Buy MDT